Relationship between skin bacterial colonization and the occurrence of allergen-specific and non-allergen-specific antibodies in sera of children with atopic eczema/dermatitis syndrome by Szakos, Erzsébet et al.
Acta Derm Venereol 2004; 84: 32-36
CLINICAL REPORT
Taylor&Francis
" healthsciences
Relationship between Skin Bacterial Colonization and the
Occurrence of Allergen-specific and Non-Allergen-specific
Antibodies in Sera of Children with Atopic Eczema/Dermatitis
Syndrome
ERZSEBET SZAKOS', GABRIELLA LAKOS^ MAGDOLNA ALEKSZA^ J A N O S HUNYADI^ MARIA FARKAS",
ENIKO S O L Y O M ' and S A N D O R SIPKA^
'Borsod-A-Z County Teaching Hospital, Pediatric Health Centre, Miskolc, ^3rd Department of Internal Medicine and ^Department of
Dermatology, University of Debrecen, Debrecen and ''Borsod-A-Z County's National Public Health Service, Bacteriologic Laboratory, Miskolc,
Hungary
In this study we investigated skin bacterial colonization,
allergen-specific IgE and antiphospholipid/antinuclear
antibodies in 72 children with atopic eczema/dermatitis
syndrome (age 2-17 years). Bacteria were found on the
skin in 41 cases and serological allergen-specific IgE
positivity in 37. The different forms of antibodies
appeared in the ratio 21/72 (33 antibodies in 21 children).
The occurrence of antiphospholipid antibodies was
significantly higher in the patients than in the controls.
There were significantly more allergens in the group with
bacterial colonization than in the group without coloniza-
tion. The SCORAD index showed a significant positive
association with the skin colonization. We conclude that
there are significant relationships between the occurrence
of Staphylococcus aureus colonization and the levels of
inhalant allergen-specific IgE in children with atopic
eczema/dermatitis syndrome, and between the occurrence
of antiphospholipid IgM positivity and atopic eczema/
dermatitis syndrome. Key words: antiphosphotipid anti-
body; inhatant altergens; bacteriat cotonization; Staphy-
tococcus aureus.
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Atopic eczema/dermatitis syndrome (AEDS) (1) is a
chronic cutaneous inflammatory disease that nearly
always begins in childhood and follows a remitting/
flaring course that continues throughout life (2-4), An
eczematous, severely pruritic disease, AEDS may be
exacerbated by several triggering factors, e,g, allergens,
irritants, seasonal/climate changes and psychic stress.
The disease often moderates with age, but patients
suffer from a life-long skin sensitivity to irritants.
Atopy predisposes patients to various occupational skin
diseases. Most, but not all, individuals with AEDS have
a personal or family history of allergic rhinitis or
asthma (5), along with increased serum IgE antibodies
against inhalant or food allergens (extrinsic type) (6, 7),
or against epithelial antigens (8, 9), The role of IgE
remains obscure, however. The skin bacterial coloniza-
tion (as a base of superantigens) and the exogenous
allergens play an important role in the progression of
the clinical status, Antinuclear (ANA) antibodies have
also been observed in an animal model of atopic
dermatitis (10), In addition, the impaired skin barrier,
sweating function (11) and ion content (12) can
contribute to the pathogenesis of AEDS, including
IgE-mediated hypersensitivity against sweat antigen
(13) or epithelial antigens (9), For a better under-
standing of the antibody pattern in AEDS (14), we
compared the occurrence of allergen-specific IgE and
antiphospholipid (APL) antibodies, including anti-
cardiolipin (ACL), and anti-P2-glucoprotein I (AP2GPI),
as well as ANA antibodies in 72 children with AEDS
from the aspect of bacterial colonization.
PATIENTS AND METHODS
Seventy-two children (34 boys, 38 girls; mean age 8 years,
range 2-17) with atopic eczema/dermatitis syndrome were
included in the study; all were suffering from serious or
medium-severe forms of the disease. The average SCORAD
index (15) was 48,3 (range 24-90), The control group
comprised 22 healthy children (10 boys, 12 girls; mean age
8,6 years, range 1,5- 14), A tampon was used to take samples
from the affected skin for microbiological examination, and
the bacteria were isolated on blood agar medium. The number
of bacteria was determined using a semiquantitative method.
The detection of ANA antibodies was carried out by indirect
immunofluorescence on HEp2 cells, ELISA assays were used
for measuring anticardiolipin and anti-P2-glycoprotein I (16),
Serum total IgE was detected by laser nephelometry. The
allergen-specific IgE was determined by an immunoblot assay
(INTEX Basel), Statistical analysis was performed using
Fisher's exact test and unpaired /-test and the odds ratio was
calculated.
Ada Derm Venereot 84 © 2004 Taylor & Francis, ISSN 0001-5555
DOI: 10,1080/00015550310015824
Children with AEDS 33
Table 1, The occurrence of non-allergen specific antinuclear (ANA) and anlipiiospholipid (APL) IgG and IgM antibodies in
children with atopic eczemaldermatitis syndrome (AEDS) and healthy controls
Antibody positivity
ANA IgG
APL IgG and/or IgM
Anticardiolipin IgM
Anticardiolipin IgG
Anti-|32-glycoprotein I IgM
Anti-p2-glycoprotein I IgG
Total number of patients with non-allergen specific
(ANA, APL) IgG and/or IgM antibodies
AEDS (n:72)
10 (14%) (9 speckled, 1 nucleolar)
18 (25%)*
12 (16%)
2 (2,7%)
6 (8,3%)
3 (4,1%)
21 (29,3%)
Healthy controls («:22)
2 (1 speckled, 1 nucleolar)
1
1
0
0
0
2
V = 0,0378,
RESULTS
Occurrence of skin bacterial positivity (colonization or
infection)
Bacteria were detectable on the skin surface in 41 of 72
patients with AEDS (57%); Staphylococcus aureus in
the great majority of cases (40/41) and Streptococcus
pyogenes in 3 cases. Double positivity was found in 2
patients. The symptoms of pyoderma were visible in 5
cases.
Occurrence of non-allergen-specific (ANA,
antiphospholipid) IgG and IgM antibodies
Elevated levels of ACL IgM appeared in 12 patients,
IgG in 2, AP2GPI IgM in 6, IgG in 3 and ANA in 10/72
(Table I), The occurrence of the 2 APL antibodies was
significantly higher in patients with AEDS (18/72) than
in controls (1/22), (/' = 0,0378), The odds ratio was 7 in
this case. On the other hand, the occurrence of ANA
positivity did not indicate any significant association
with AEDS,
Occurrence and types of allergen-specific IgE
We found 37 children with some type of allergen-
specific IgE positivity (51%), In the 72 patients with
AEDS, the most frequent allergens were inhalant types:
rye pollen (34,7%), mites (22,2%), weeds (22,2), grasses
(20,8%), cat and/or dog epithelium (20,8%), trees
(12,5%), The occurrence of corn (8,3%), soy (8,3%)
and tomato (6,9%) positivity was less common. We did
not consider positivity of less than 6% (Table II),
Correlation between non-allergen-specific antibodies,
total and allergen-specific IgE
There was no statistically significant difference between
the occurrence of non-allergen-specific (ANA, APL)
antibodies in patients with normal (11/31=35%) and
high (10/41=24%) serum total IgE, However, the
appearance of non-allergen-speciflc antibodies was
significantly higher in children with AEDS presenting
normal serum levels of IgE than in the healthy controls
{p = 0.0\69, odds ratio 10,5) (Table III), It was not a
surprise that there were great differences in total and
allergen-specific IgE levels between patients and con-
trols. Whereas elevated serum total IgE was seen in
41/72 (57%) of the children with AEDS only 9,1% of
the controls showed the feature (/> = 0,0001, odds ratio
13,226), The number of patients with allergen-specific
IgE positivity (suffering from the extrinsic type of
AEDS) was 37 of 72 (51%) versus 0/22 among controls
(/? = 0,0001, odds ratio 44,5) (Table III),
Occurrence of ANA, antiphospholipid and
allergen-specific IgE positivity in children with and
without existing skin bacterial colonization
There was no significant relation between in the
appearance of APL or ANA antibodies and the
presence of bacterial colonization in AEDS children.
On the other hand, the total number of allergen-specific
IgE positive in children with extrinsic AEDS (« = 37)
was significantly higher in those with bacterial coloni-
zation (92/20) than in those without bacterial coloniza-
tion (36/17), (/7 = 0,0474, odds ratio 2,17), In particular,
rye-specific IgE positivity was significantly higher in
the colonized group (17/41) than in the non-colonized
Table II, Occurrence and types of allergen-specific IgE in
children with extrinsic (37172 eases) type of atopic eczemal
dermatitis syndrome
Types of allergen
Rye
Dermatophagoides pteron, D,farin,
Weeds
Grasses
Cat and/or dog
Trees
Corn
Soy
Tomato
Wheat
Nuts
Orange
Mould
Milk
Egg
Fish
No, of positive cases (%)
24 (34.7)
16 (22.2)
16 (22.2)
14 (20.8)
14 (20.8)
8 (12,5)
6 (8,3)
6 (8,3)
5 (6,9)
4 (5,5)
4 (5,5)
4 (5,5)
3 (4,0)
2(3,1)
1 (1,5)
1 (1,5)
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Table III. Occurrence of non-allergen-specific antibodies and allergen-specific IgE in relation to total IgE levels in sera of
children with atopic eczemaldermatitis syndrome (AEDS) and healthy controls
Laboratory findings AEDS (« = 72)i
Healthy controls
(« = 22) (%)
Elevated serum total IgE
Allergen-specific IgE positivity
Non-allergen-specific antibodies
(ANA and/or APL) together with:
normal serum level of IgE
high serum levels of IgE
Antiphospholipid antibodies together with:
absence of allergen-specific IgE
presence of allergen-specific IgE
41 (57%)**
37 (51%)**
11/31 (35%)*
11/41 (24%)
7/35 (20%)
9/37 (27%)
2 (9.1%)
0 (0%)
1/20 (5%)
1/2 (50%)
1/22 (5%)
0/0 (0%)
*/) = 0.0169, **p = 0.0001.
APL: antiphospholipid.
group (7/31), (;7 = 0.0184, odds ratio 4.25). These data
suggest that the existence of bacterial colonization
on the skin could predispose the patients with AEDS
to polysensibilization, mainly to inhalant allergens
(Table IV).
Linkage between bacterial colonization, ANA,
antiphospholipid, allergen-specific IgE positivity and
SCORAD index
The average SCORAD index was 48.3 in the 72
children with AEDS, but there was no difference in the
SCORAD index of patients with bacterial colonization
(53.2), ANA (52.9), ACL (52.3), APL (49.9), combined
ANA and/or APL (50.2) and allergen-specific IgE
positivity. On the other hand, there was a strong
association between a SCORAD index higher than 48.3
and the existence of bacterial colonization (p = 0.0007,
odds ratio 6.5) (Table V).
DISCUSSION
Although there have been many previous studies
focusing on the role of skin colonizing bacteria,
exogenous allergens, cytokines, other local and systemic
findings (7, 17-23), this is the first to analyse the
occurrence of antiphospholipid and antinuclear anti-
bodies and their potential connection with skin
bacterial colonization in children with AEDS. Our
results show that APL IgM (mainly anticardiolipin)
and ANA IgG are the two types of antibodies that
Table IV. The occurrence of antinuclear antibodies (ANA) antiphospholipid (APL) and allergen-specific IgE positivity in children
with atopic eczemaldermatitis syndrome with and without skin bacterial colonization
Antibody positivity
Non-allergic lype.s:
ANA
Anticardiolipin
ANA + anticardiolipin
Antiphospholipid (anticardiolipin and/or anti-(32-gycoproteinI)
Number of patients with non-allergen-specific antibodies
(ANA and/or ACL and/or AP2GPI)
Total number of non-allergen-specific antibodies
Allergen specific IgE:
Rye
Mite
Weed
Pet (cat, dog)
Grass
Tree
Corn
Soy
Tomato
Number of patients with allergen-specific IgE
Total number of the allergen-specific IgE antibodies
Patients with bacterial
colonization («:41)
n(%)
8 (19.5%)
9 (22%)
5 (12.2%)
12 (29.2%)
15 (36.5%)
22/15
17 (41.5%)*
12 (29.3%)
11 (26.8%)
11 (26.8%)
10 (24.4%)
5 (12.2%)
4 (9.7%)
3 (7.3%)
3 (7.3%)
20 (48.8%)
92/20**
Patients without bacterial
colonization {n.2t\)
n(%)
2 (6.4%)
4 (13%)
2 (6.4%)
6 (19%)
6 (19.2%)
11/6
7 (22.6%)
4(13%)
5 (16.1%)
3 (9.7%)
4(13%)
3 (9.7%)
2 (6.4%)
3 (9.7%)
2 (6.4%)
17 (54.8%)
36/17
) = 0.0184, **/ , = 0,0474.
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Table V. Occurrence of bacterial colonization, non-allergen-specific (ANA or APL) and allergen-specific antibodies in children
with atopic eczemaldermatitis syndrome having a SCORAD index higher or lower than average (mean: 48.3)
Patients with SCORAD >48,3 (« = 31) ( SCORAD <48.3 (« = 41) (%)
Bacterial colonization (« = 4I)
ANA positivity (n= 10)
APL positivity (n=18)
ANA and/or APL positivity (« = 2I)
Allergen-specific IgE positivity (n = 37)
25 (60.9)*
5 (50%)
6 (33.3%)
9 (42.9)
18 (48.6)
16 (39.1)*
5 (50%)
12 (66.7%)
12 (57.1%)
19 (51.4%)
*/) = 0.0007.
APL: antiphospholipid; ANA: antinuclear antibodies.
show a more frequent occurrence in the AEDS children
than in the controls. Furthermore, allergen-specific IgE
against rye, mites, weeds, pets and grasses, appeared
with higher rates in these patients than in the healthy
controls. We assume that some lipid components of
these inhalant allergens might provoke the production
of APL antibodies, known to be often elevated in
microbial infections (24, 25).
It is of special interest that in patients with bacterial
colonization the total number of allergen-specific
antibodies was significantly higher than in those
without pyogenic skin bacteria. The mechanism of
this unusual polysensitization toward inhalant allergens
could be the facilitated antigen penetration through the
impaired skin epithelium in children with an extrinsic
type of atopic dermatitis. On the other hand, the
occurrence of non-allergic, APL or ANA antibodies
was only slightly elevated in the group of atopic
patients with colonization compared to those without
bacteria. Patients with a SCORAD index higher than
48.3 showed significant association with bacterial
colonization. It is therefore concluded that the presence
of pyogenic bacteria on the skin of patients with AEDS
could contribute not only to the severity of disease, but
also to the polysensitization toward some inhalant
allergens, especially in patients with high total IgE,
representing the extrinsic type of the disease. On the
other hand, the appearance of antibodies toward APL
and ANA seemed to be independent of atopic diathesis,
and more related to the intrinsic type of AEDS.
Perhaps these types of antibodies are produced against
the phospholipid and nucleoprotein components of
inhalant and bacterial antigens attached to a genetically
impaired skin of patients with AEDS (4, 26), i.e.
identical to those that provoke the diverse allergen-
specific IgE response in the atopic subgroup of AEDS
(22, 23). In this phenomenon, the lack of Th2 switch
could also be an explanation of a dominant IgM/IgG
antibody production and only a few IgE sensitizations
(4). It is also possible, however, that the APL
antibodies are produced against some still unidentified
internal antigens and hence represent an indirect sign of
the intrinsic character of AEDS.
According to our data, the high frequencies of
inhalant allergen-specific IgE and APL/ANA antibodies
can be markers of an abberant antigen (allergen)
uptake by patients with AEDS, but they cannot be
primary causative factors in the induction of the
disease. According to the types of antibodies, the
patients with AEDS can be divided into two subgroups:
group A - atopic patients with elevated total serum
IgE or allergen-specific IgE toward a great number of
inhalant allergens, and with a rare occurrence of APL/
ANA antibodies; group B - non-atopic patients with
normal level of total serum IgE, and with more
frequent occurrence of APL/ANA antibodies. However,
the genetically impaired skin barrier is probably the
crucial factor in the pathogenesis of AEDS (4, 11, 12,
26). In addition, secondary damage to the skin caused
by pyogenic bacteria can probably modify the barrier
function of epithelium further. Finally, the primary or
secondary disturbance of immunoregulation cannot be
neglected (4). From a clinical point of view, we
recommend that the presence or absence of bacterial
colonization on the skin should be determined, and the
various inhalant allergen-specific IgE levels character-
ized in patients with AEDS. Analysis of ALP and ANA
antibodies does not seem to be of major importance.
Although such measurement may suggest the intrinsic
subtype of the disease, it has to be stressed that APL
antibodies can occur in low frequency also in patients
with the extrinsic type of AEDS.
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